Sera Prognostics Announces Pricing of Initial Public Offering
July 14, 2021 21:03 ET | Source: Sera Prognostics Sera Prognostics
SALT LAKE CITY, July 14, 2021 (GLOBE NEWSWIRE) Sera Prognostics Inc., The Pregnancy Company
® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share. The gross proceeds to Sera from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be approximately $75.0 million. The shares are expected to begin trading on the Nasdaq Global Market on July 15, 2021 under the symbol “SERA.” The offering is expected to close on July 19, 2021, subject to customary closing conditions. In addition, Sera has granted the underwriters a 30-day opt
Photo by Ariel Skelley/Getty Images
Halma, a UK-based health tech company, snapped up perinatal and prenatal health AI company PeriGen for $58 million earlier this week.
Founded in 2000, PeriGen makes software products focused on the childbirth process that give clinicians more patient data based on algorithms and analysis. Its Early Warning System and Clinical Decision Support tool is able to use artificial intelligence to monitor patients in labor and find any potential issues that need to be addressed in a timely manner.
The tool was designed to help clinicians interpret complex data. It provides central surveillance and patient census, as well as bedside surveillance.